Publications by authors named "Yunqi Mi"
Article Synopsis
- Japanese encephalitis virus (JEV) causes severe brain inflammation (Japanese encephalitis) in humans, resulting in ~68,000 cases and significant mortality each year, with about one-third of cases being fatal.
- While vaccination is the primary prevention method, current vaccines are not effective against all JEV strains, and there are no approved drugs for treatment, heightening the need for new therapeutic options.
- The paper highlights the potential of bioactive natural products as a promising avenue for developing anti-JEV drugs due to their diverse sources, unique structures, and cost-effectiveness.
Japanese encephalitis virus (JEV) belongs to the family and is a representative mosquito-borne flavivirus responsible for acute encephalitis and meningitis in humans. Despite the availability of vaccines, JEV remains a major public health threat with the potential to spread globally. According to the World Health Organization (WHO), there are an estimated 69,000 cases of JE each year, and this figure is probably an underestimate.
View Article and Find Full Text PDF